Impact of Insulin-Treated Compared to Non-Insulin-Treated Diabetes Mellitus on Outcome of Percutaneous Coronary Intervention with Drug-Coated Balloons versus Drug-Eluting Stents in De Novo Coronary Artery Disease: The Randomized BASKET-SMALL 2 Trial.
Julia SeegerJochen WöhrleBruno SchellerAhmed FarahMarc-Alexander OhlowNorman MangnerSven Möbius-WinklerDaniel WeilenmannGeorg StachelGregor LeibundgutPeter RickenbacherMarco CattaneoNicole GilgenChristoph KaiserRaban V Jegernull On Behalf Of The Basket-Small InvestigatorsPublished in: Journal of cardiovascular development and disease (2023)
DCB compared to DES for treatment of de novo coronary lesions in diabetic patients was associated with similar rates of MACE and numerically lower need for TVR both for ITDM and NITDM patients.
Keyphrases
- coronary artery disease
- percutaneous coronary intervention
- type diabetes
- newly diagnosed
- end stage renal disease
- phase iii
- glycemic control
- ejection fraction
- phase ii
- st segment elevation myocardial infarction
- coronary artery bypass grafting
- peritoneal dialysis
- chronic kidney disease
- double blind
- acute coronary syndrome
- acute myocardial infarction
- randomized controlled trial
- heart failure
- prognostic factors
- aortic stenosis
- clinical trial
- antiplatelet therapy
- cardiovascular disease
- study protocol
- emergency department
- skeletal muscle
- st elevation myocardial infarction
- coronary artery bypass
- patient reported outcomes
- insulin resistance
- replacement therapy